College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Integris Pulmonology Associates of Enid, Enid, Oklahoma.
Am J Med Sci. 2021 Jan;361(1):111-117. doi: 10.1016/j.amjms.2020.07.010. Epub 2020 Jul 10.
Endobronchial lipomas are rare benign tumors that can cause bronchial obstruction resulting in significant symptoms and post-obstructive parenchymal damage. Accurate diagnosis and treatment are essential to avoid unnecessary morbidity and mortality in these patients. We describe one case of endobronchial lipoma at our institution and include a literature review of endobronchial lipoma cases reported during the time period 2003-2018. Treatment has shifted towards bronchoscopic management and away from surgery for the majority of patients; 64.3% of patients in this review had their lipoma resected bronchoscopically, compared to 30% or less in reviews as recent as 2003. Notably, in cases reported since 2010, 72.7% of cases were managed bronchoscopically. Recurrence rates are low following both bronchoscopic and surgical resection.
支气管脂肪瘤是罕见的良性肿瘤,可导致支气管阻塞,引起明显的症状和阻塞后实质损伤。准确的诊断和治疗对于避免这些患者发生不必要的发病率和死亡率至关重要。我们描述了我院的一例支气管脂肪瘤病例,并对 2003-2018 年间报告的支气管脂肪瘤病例进行了文献复习。治疗已经从手术转向支气管镜下治疗,对于大多数患者来说,这种转变已经发生;在本综述中,64.3%的患者通过支气管镜切除脂肪瘤,而在 2003 年前后的综述中,这一比例为 30%或更低。值得注意的是,在 2010 年以后报告的病例中,72.7%的病例通过支气管镜进行了治疗。支气管镜和手术切除后复发率均较低。